宿主-微生物组平衡:揭示影响健康和疾病的复杂相互作用

IF 5.6 2区 医学 Q1 PHYSIOLOGY
Pontus B. Persson
{"title":"宿主-微生物组平衡:揭示影响健康和疾病的复杂相互作用","authors":"Pontus B. Persson","doi":"10.1111/apha.70034","DOIUrl":null,"url":null,"abstract":"<p>The relationship between the human body and its microbial communities is becoming increasingly recognized as essential to our overall health. What we once thought of as a mere collection of bacteria, fungi, and other microorganisms now turns out to play a far more active role in maintaining our health or contributing to disease. This connection, known as host-microbiome homeostasis, refers to the balance between our bodies and the microbes residing within us. When this balance is disrupted, it can lead to conditions such as obesity, asthma, epilepsy, and even heart disease. Recent studies in this field shed light on the nature of this coexistence and pave the way toward therapies that harness the power of the microbiome to treat a variety of health issues.</p><p>This special series builds on Acta Physiologica's strong standing in the field<span><sup>1-3</sup></span> and comprises studies delving into different aspects of microbiome research. From using engineered bacteria to fight metabolic diseases to exploring the role of diet and early-life microbial exposure in asthma, these studies highlight just how interconnected our health is with the microbes living in and on us.</p><p>One of the studies, led by Ciocan and Elinav,<span><sup>4</sup></span> explores the idea of using genetically engineered bacteria to change the gut microbiome in ways that can treat disorders like obesity and diabetes. It is a fascinating step toward developing new treatments that could shift the balance of the microbiome for better health. A further article highlights the gut-lung axis and how early-life microbiota might influence asthma. Early-life exposures to microbes may play a major role in determining whether a child is more likely to develop asthma. Factors like how babies are born, whether they are breastfed, and their early diets all influence the development of their gut microbiome, which in turn affects immune responses. This could mean that by targeting the microbiome early on, there may be new opportunities to prevent asthma before it even begins. Pirr and colleagues explore the neonate respiratory microbiome.<span><sup>5</sup></span> For a long time, we assumed that the respiratory tract was relatively sterile; yet, like the gut, it is home to a variety of microbes. The study reveals how the respiratory microbiome develops in newborns and how factors like delivery method, diet, and early infections can shape the microbial communities in the lungs. Understanding how these microbial communities interact with the immune system could lead to new ways to prevent respiratory diseases in children.</p><p>Diet is another area where the microbiome shows its influence, as outlined by Schoeler and his team.<span><sup>6</sup></span> We know that drastic changes in diet can dramatically alter the gut microbiome. This study explores the more subtle effects of typical, everyday dietary variations. By observing how small shifts in diet influence the gut microbiota in both humans and mice, the research suggests that even moderate dietary changes can lead to noticeable changes in microbial composition, potentially offering a more personalized approach to diet-based health interventions.</p><p>Moving into the realm of neurology, Diaz-Marugan and colleagues focus on epilepsy.<span><sup>7</sup></span> Some patients with drug-resistant epilepsy struggle to find further treatment options. The microbiome of these patients appears different from that of those whose epilepsy responds to treatment. Interestingly, therapies like the ketogenic diet, which have been used to treat epilepsy, may work by influencing the gut microbiome.</p><p>Metformin, a drug commonly used to treat diabetes, has also been shown to have surprising effects beyond blood sugar regulation. Wimmer's study shows that metformin can influence the gut microbiome,<span><sup>8</sup></span> increasing the production of short-chain fatty acids, which have anti-inflammatory effects. These changes were linked to improvements in blood pressure and heart function in rats, even in the absence of diabetes. This finding suggests that metformin could have additional cardiovascular benefits by way of the microbiome, which is an exciting area for further investigation.</p><p>The special series illustrates how deeply our health is intertwined with the microbiome and the many ways in which microbial communities can influence everything from metabolism to brain health, and even our immune systems. As we learn more about the microbiome, it becomes clearer that restoring or maintaining a healthy microbial balance could be key to treating a wide range of diseases.<span><sup>9, 10</sup></span> With these findings, the future of medicine may be more about understanding and working with our microbes rather than against them.</p>","PeriodicalId":107,"journal":{"name":"Acta Physiologica","volume":"241 4","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2025-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apha.70034","citationCount":"0","resultStr":"{\"title\":\"Host-microbiome homeostasis: Unveiling the complex interactions shaping health and disease\",\"authors\":\"Pontus B. Persson\",\"doi\":\"10.1111/apha.70034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The relationship between the human body and its microbial communities is becoming increasingly recognized as essential to our overall health. What we once thought of as a mere collection of bacteria, fungi, and other microorganisms now turns out to play a far more active role in maintaining our health or contributing to disease. This connection, known as host-microbiome homeostasis, refers to the balance between our bodies and the microbes residing within us. When this balance is disrupted, it can lead to conditions such as obesity, asthma, epilepsy, and even heart disease. Recent studies in this field shed light on the nature of this coexistence and pave the way toward therapies that harness the power of the microbiome to treat a variety of health issues.</p><p>This special series builds on Acta Physiologica's strong standing in the field<span><sup>1-3</sup></span> and comprises studies delving into different aspects of microbiome research. From using engineered bacteria to fight metabolic diseases to exploring the role of diet and early-life microbial exposure in asthma, these studies highlight just how interconnected our health is with the microbes living in and on us.</p><p>One of the studies, led by Ciocan and Elinav,<span><sup>4</sup></span> explores the idea of using genetically engineered bacteria to change the gut microbiome in ways that can treat disorders like obesity and diabetes. It is a fascinating step toward developing new treatments that could shift the balance of the microbiome for better health. A further article highlights the gut-lung axis and how early-life microbiota might influence asthma. Early-life exposures to microbes may play a major role in determining whether a child is more likely to develop asthma. Factors like how babies are born, whether they are breastfed, and their early diets all influence the development of their gut microbiome, which in turn affects immune responses. This could mean that by targeting the microbiome early on, there may be new opportunities to prevent asthma before it even begins. Pirr and colleagues explore the neonate respiratory microbiome.<span><sup>5</sup></span> For a long time, we assumed that the respiratory tract was relatively sterile; yet, like the gut, it is home to a variety of microbes. The study reveals how the respiratory microbiome develops in newborns and how factors like delivery method, diet, and early infections can shape the microbial communities in the lungs. Understanding how these microbial communities interact with the immune system could lead to new ways to prevent respiratory diseases in children.</p><p>Diet is another area where the microbiome shows its influence, as outlined by Schoeler and his team.<span><sup>6</sup></span> We know that drastic changes in diet can dramatically alter the gut microbiome. This study explores the more subtle effects of typical, everyday dietary variations. By observing how small shifts in diet influence the gut microbiota in both humans and mice, the research suggests that even moderate dietary changes can lead to noticeable changes in microbial composition, potentially offering a more personalized approach to diet-based health interventions.</p><p>Moving into the realm of neurology, Diaz-Marugan and colleagues focus on epilepsy.<span><sup>7</sup></span> Some patients with drug-resistant epilepsy struggle to find further treatment options. The microbiome of these patients appears different from that of those whose epilepsy responds to treatment. Interestingly, therapies like the ketogenic diet, which have been used to treat epilepsy, may work by influencing the gut microbiome.</p><p>Metformin, a drug commonly used to treat diabetes, has also been shown to have surprising effects beyond blood sugar regulation. Wimmer's study shows that metformin can influence the gut microbiome,<span><sup>8</sup></span> increasing the production of short-chain fatty acids, which have anti-inflammatory effects. These changes were linked to improvements in blood pressure and heart function in rats, even in the absence of diabetes. This finding suggests that metformin could have additional cardiovascular benefits by way of the microbiome, which is an exciting area for further investigation.</p><p>The special series illustrates how deeply our health is intertwined with the microbiome and the many ways in which microbial communities can influence everything from metabolism to brain health, and even our immune systems. As we learn more about the microbiome, it becomes clearer that restoring or maintaining a healthy microbial balance could be key to treating a wide range of diseases.<span><sup>9, 10</sup></span> With these findings, the future of medicine may be more about understanding and working with our microbes rather than against them.</p>\",\"PeriodicalId\":107,\"journal\":{\"name\":\"Acta Physiologica\",\"volume\":\"241 4\",\"pages\":\"\"},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2025-03-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apha.70034\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Physiologica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/apha.70034\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHYSIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Physiologica","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apha.70034","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHYSIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

人体与其微生物群落之间的关系越来越被认为对我们的整体健康至关重要。我们曾经认为的仅仅是细菌、真菌和其他微生物的集合,现在却证明在维持我们的健康或导致疾病方面发挥着更为积极的作用。这种联系被称为宿主-微生物群稳态,指的是我们的身体和我们体内的微生物之间的平衡。当这种平衡被破坏时,就会导致肥胖、哮喘、癫痫甚至心脏病等疾病。该领域最近的研究揭示了这种共存的本质,并为利用微生物群的力量治疗各种健康问题铺平了道路。这个特别的系列建立在《生理学学报》在该领域的强大地位1-3之上,包括深入研究微生物组研究的不同方面。从使用工程细菌对抗代谢疾病到探索饮食和早期微生物暴露在哮喘中的作用,这些研究强调了我们的健康与生活在我们体内和体表的微生物是如何相互关联的。其中一项由Ciocan和Elinav领导的研究探索了利用基因工程细菌改变肠道微生物群的想法,以治疗肥胖和糖尿病等疾病。这是朝着开发新的治疗方法迈出的令人着迷的一步,这些治疗方法可以改变微生物群的平衡,以改善健康状况。另一篇文章强调了肠-肺轴以及早期微生物群如何影响哮喘。儿童早期接触微生物可能在决定儿童是否更容易患哮喘方面发挥重要作用。婴儿出生方式、是否母乳喂养、早期饮食等因素都会影响肠道微生物群的发育,进而影响免疫反应。这可能意味着,通过早期瞄准微生物群,可能有新的机会在哮喘开始之前就预防它。皮尔和他的同事们研究了新生儿呼吸道微生物群很长一段时间以来,我们都认为呼吸道是相对无菌的;然而,就像肠道一样,它是各种微生物的家园。这项研究揭示了新生儿的呼吸微生物群是如何发育的,以及分娩方式、饮食和早期感染等因素是如何塑造肺部微生物群落的。了解这些微生物群落如何与免疫系统相互作用可能会导致预防儿童呼吸道疾病的新方法。正如舍勒和他的团队所概述的那样,饮食是微生物群显示其影响的另一个领域我们知道饮食的剧烈变化会极大地改变肠道微生物群。这项研究探讨了典型的日常饮食变化的更微妙的影响。通过观察饮食的微小变化如何影响人类和小鼠的肠道微生物群,研究表明,即使是适度的饮食变化也会导致微生物组成的明显变化,这可能为基于饮食的健康干预提供更个性化的方法。进入神经学领域后,迪亚兹-马鲁根和他的同事们把重点放在了癫痫上一些耐药癫痫患者难以找到进一步的治疗方案。这些患者的微生物组似乎不同于那些对治疗有反应的癫痫患者。有趣的是,像生酮饮食这样用于治疗癫痫的疗法,可能是通过影响肠道微生物群来起作用的。二甲双胍是一种常用的治疗糖尿病的药物,除了血糖调节外,它还有令人惊讶的作用。温默的研究表明,二甲双胍可以影响肠道微生物群,8增加具有抗炎作用的短链脂肪酸的产生。这些变化与大鼠血压和心脏功能的改善有关,即使在没有糖尿病的情况下也是如此。这一发现表明,二甲双胍可能通过微生物群对心血管有额外的益处,这是一个令人兴奋的领域,有待进一步研究。这个特别系列展示了我们的健康是如何与微生物群紧密相连的,以及微生物群落如何以多种方式影响从新陈代谢到大脑健康,甚至我们的免疫系统的一切。随着我们对微生物组的了解越来越多,恢复或维持健康的微生物平衡可能是治疗多种疾病的关键,这一点变得越来越清楚。9,10有了这些发现,医学的未来可能更多地是了解和利用我们的微生物,而不是对抗它们。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Host-microbiome homeostasis: Unveiling the complex interactions shaping health and disease

The relationship between the human body and its microbial communities is becoming increasingly recognized as essential to our overall health. What we once thought of as a mere collection of bacteria, fungi, and other microorganisms now turns out to play a far more active role in maintaining our health or contributing to disease. This connection, known as host-microbiome homeostasis, refers to the balance between our bodies and the microbes residing within us. When this balance is disrupted, it can lead to conditions such as obesity, asthma, epilepsy, and even heart disease. Recent studies in this field shed light on the nature of this coexistence and pave the way toward therapies that harness the power of the microbiome to treat a variety of health issues.

This special series builds on Acta Physiologica's strong standing in the field1-3 and comprises studies delving into different aspects of microbiome research. From using engineered bacteria to fight metabolic diseases to exploring the role of diet and early-life microbial exposure in asthma, these studies highlight just how interconnected our health is with the microbes living in and on us.

One of the studies, led by Ciocan and Elinav,4 explores the idea of using genetically engineered bacteria to change the gut microbiome in ways that can treat disorders like obesity and diabetes. It is a fascinating step toward developing new treatments that could shift the balance of the microbiome for better health. A further article highlights the gut-lung axis and how early-life microbiota might influence asthma. Early-life exposures to microbes may play a major role in determining whether a child is more likely to develop asthma. Factors like how babies are born, whether they are breastfed, and their early diets all influence the development of their gut microbiome, which in turn affects immune responses. This could mean that by targeting the microbiome early on, there may be new opportunities to prevent asthma before it even begins. Pirr and colleagues explore the neonate respiratory microbiome.5 For a long time, we assumed that the respiratory tract was relatively sterile; yet, like the gut, it is home to a variety of microbes. The study reveals how the respiratory microbiome develops in newborns and how factors like delivery method, diet, and early infections can shape the microbial communities in the lungs. Understanding how these microbial communities interact with the immune system could lead to new ways to prevent respiratory diseases in children.

Diet is another area where the microbiome shows its influence, as outlined by Schoeler and his team.6 We know that drastic changes in diet can dramatically alter the gut microbiome. This study explores the more subtle effects of typical, everyday dietary variations. By observing how small shifts in diet influence the gut microbiota in both humans and mice, the research suggests that even moderate dietary changes can lead to noticeable changes in microbial composition, potentially offering a more personalized approach to diet-based health interventions.

Moving into the realm of neurology, Diaz-Marugan and colleagues focus on epilepsy.7 Some patients with drug-resistant epilepsy struggle to find further treatment options. The microbiome of these patients appears different from that of those whose epilepsy responds to treatment. Interestingly, therapies like the ketogenic diet, which have been used to treat epilepsy, may work by influencing the gut microbiome.

Metformin, a drug commonly used to treat diabetes, has also been shown to have surprising effects beyond blood sugar regulation. Wimmer's study shows that metformin can influence the gut microbiome,8 increasing the production of short-chain fatty acids, which have anti-inflammatory effects. These changes were linked to improvements in blood pressure and heart function in rats, even in the absence of diabetes. This finding suggests that metformin could have additional cardiovascular benefits by way of the microbiome, which is an exciting area for further investigation.

The special series illustrates how deeply our health is intertwined with the microbiome and the many ways in which microbial communities can influence everything from metabolism to brain health, and even our immune systems. As we learn more about the microbiome, it becomes clearer that restoring or maintaining a healthy microbial balance could be key to treating a wide range of diseases.9, 10 With these findings, the future of medicine may be more about understanding and working with our microbes rather than against them.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Acta Physiologica
Acta Physiologica 医学-生理学
CiteScore
11.80
自引率
15.90%
发文量
182
审稿时长
4-8 weeks
期刊介绍: Acta Physiologica is an important forum for the publication of high quality original research in physiology and related areas by authors from all over the world. Acta Physiologica is a leading journal in human/translational physiology while promoting all aspects of the science of physiology. The journal publishes full length original articles on important new observations as well as reviews and commentaries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信